T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics. (2018)

First Author: Herbert KJ

Attributed to: Molecular Determinants of Radiosensitivity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41419-018-1131-7

PubMed Identifier: 30356039

Publication URI: http://europepmc.org/abstract/MED/30356039

Type: Journal Article/Review

Volume: 9

Parent Publication: Cell death & disease

Issue: 11